نتایج جستجو برای: tenecteplase

تعداد نتایج: 297  

2013
Gurpreet Singh Wander Shibba Takkar Chhabra

Thrombolytics recanalize thrombotic occlusion associated with STsegment elevation myocardial infarction (STEMI) and restoration of coronary flow reduces infarct size and improves myocardial function and survival over the short-term and long-term. Thrombolytic therapy for acute myocardial infarction (AMI) was incorporated into the armamentarium of clinicians over 2 decades ago, and has evolved f...

Journal: :International journal of cardiology 2015
Kristian Hellenkamp Anja Kaeberich Johanna Schwung Stavros Konstantinides Mareike Lankeit

Article history: Received 5 June 2015 Accepted 20 June 2015 Available online 27 June 2015 over, laboratory testing showed elevated plasma concentrations of high-sensitivity troponin T (hsTnT, 65.8 ng/l; reference b14 ng/l [2]) and N-terminal pro-brain natriuretic peptide (NT-proBNP, 9024 pg/ml; reference b600 pg/ml [3]). Since the patient met all inclusion and no exclusion criteria, shewas incl...

Journal: :Circulation 2004
C Michael Gibson Lisa K Jennings Sabina A Murphy David P Lorenz Robert P Giugliano Robert A Harrington Shila Cholera Rajini Krishnan Robert M Califf Eugene Braunwald

BACKGROUND Paradoxically, fibrinolytic agents may systemically activate platelets, which in turn secrete plasminogen activator inhibitor (PAI-1), an antagonist of the fibrinolytic process in proportion to total body platelet mass. We hypothesized that improved epicardial patency, myocardial perfusion, and ST-segment resolution would be associated with higher levels of platelet receptor occupanc...

Journal: :Chest 2004
Venu Menon Robert A Harrington Judith S Hochman Christopher P Cannon Shaun D Goodman Robert G Wilcox Holger J Schünemann E Magnus Ohman

This chapter about antithrombotic therapy for acute myocardial infarction (MI) is part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that individual patients' values may lead to different choices (for a full ...

Journal: :Current issues in pharmacy and medicine: science and practice 2018

Journal: :Chest 2008
Shaun G Goodman Venu Menon Christopher P Cannon Gabriel Steg E Magnus Ohman Robert A Harrington

This chapter about fibrinolytic, antiplatelet, and antithrombin treatment for acute ST-segment elevation (STE) myocardial infarction (MI) is part of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that individual...

2012
Prashanth Panduranga Ibrahim Al-Zakwani Kadhim Sulaiman Khalid Al-Habib Jassim Al Suwaidi Ahmed Al-Motarreb Alawi Alsheikh-Ali Shukri Al Saif Hussam Al Faleh Wael Almahmeed Nidal Asaad Haitham Amin Jawad Al-Lawati Ahmad Hersi

OBJECTIVE Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in hospital within 12 hours from pain onset and received thrombolytic therapy. PATIENTS AND METHODS This was a prospective, multinational, multi...

Journal: :Journal of the American College of Cardiology 2007
Michael Dandel Hans Lehmkuhl Christoph Knosalla Roland Hetzer

1. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941–7. 2. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771–5. 3. Brodie BR, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید